Nyxoah SA (EBR:NYXH)
Belgium
· Delayed Price · Currency is EUR 4.280
+0.155 (3.76%)
Last updated: Dec 5, 2025, 3:13 PM CET
Nyxoah Revenue
Nyxoah had revenue of 1.97M EUR in the quarter ending September 30, 2025, with 55.77% growth. This brings the company's revenue in the last twelve months to 5.64M, up 10.96% year-over-year. In the year 2024, Nyxoah had annual revenue of 4.52M with 3.98% growth.
Revenue (ttm)
5.64M
Revenue Growth
+10.96%
P/S Ratio
32.66
Revenue / Employee
30.65K
Employees
184
Market Cap
184.15M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| argenx SE | 3.14B |
| UCB SA | 6.85B |
| Financière de Tubize | 13.26K |
| Fagron NV | 918.75M |
| Ion Beam Applications | 585.76M |
| Onward Medical | 2.72M |
| Hyloris Pharmaceuticals | 8.46M |
| Sequana Medical NV | 105.50K |